2 September 2022 - Azurity Pharmaceuticals announced today that the US FDA has approved Konvomep (omeprazole and sodium bicarbonate for oral ...
31 August 2022 - IPX203 is a novel, extended-release oral formulation of carbidopa and levodopa that if approved, would offer patients ...
22 August 2022 - Otsuka and Astex Pharmaceuticals today announce that the EMA has accepted the marketing authorisation application for the ...
19 August 2022 - Auvelity is the first and only rapid-acting oral treatment approved with labelling of statistically significant improvement in ...
5 August 2022 - Data from the Phase 3 SPIRIT program showed Myfembree reduced menstrual pain and non-menstrual pelvic pain in ...
30 June 2022 - Final results from EPIC-HR study showed an 86% reduction in relative risk of hospitalisations or death from ...
22 June 2022 - This approval is supported by 98.4 per cent cure rate across this group of patients who ...
15 June 2022 - This marks the first TGA approval for Jazz Pharmaceuticals. ...
13 June 2022 - Health Canada decision signifies the first global regulatory approval for Amylyx and the first new therapy for ...
3 June 2022 - New PDUFA goal date scheduled for 29 September 2022 to allow time to review additional data ...
26 May 2022 - Pfizer today announced the U.S. FDA has granted fast track designation to Pfizer’s investigational combination therapy ...
20 May 2022 - Submission is supported by Phase 3 study that demonstrated patients had significant increases in hours of ...
3 May 2022 - U.S. commercial launch anticipated in the third quarter of 2022. ...
20 April 2022 - Vertex has submitted this indication to CADTH & INESSS for health technology assessments. ...
14 April 2022 - Evusheld is the first long-acting antibody combination to receive Health Canada authorisation for the prevention of ...